Emerging research employed lentivirus-mediated shRNA to knock down GLP-1R expression in vitro, resulting in diminished effects of GLP-1RAs on mitochondrial function by day 21, along with impaired mitochondrial autophagy and autophagic clearance
31, according to the Defense Health Agency
While Trulicity and Ozempic belong to the same drug class called GLP-1 receptor agonists and have the same mechanism of action, they differ in their structure, the way they are processed by the body and their clinical effects
Given the uncertainty of this outcome, additional clinical studies of obese AUD patients should explore the effects of the GLP-1R agonists on alcohol intake and body weight
I'm not saying do this, by the way, if you're healthy, no risk at all
It is designed to support weight loss when used alongside a reduced-calorie diet and increased physical activity